Amedisys, Inc. (NASDAQ:AMED) reported adjusted fourth fiscal quarter EPS of
$0.95 versus consensus of $0.91 on revenues of $394 million yesterday. The
company reported net income of $22.1 million or 77 cents a share during the
fourth fiscal quarter, down $15.7 or 41.5% from $37.8 million or $1.35 a share
in 2009. On an adjusted basis, the company earned 95 cents a share, beating the
analysts' expectation by 4 cents. The company also reported a decrease of
$11.2 or 2.8% in its net service revenue of $394.3 million during the quarter
from $405.5 million in 2009, missing the street estimate of $400.1 million. EBIT
margins in the hospice segment were 26.9% in the latest quarter, up from 17.7%
in the third quarter and 19.9% during the first three quarters of 2010. The
average revenue per completed episode in the home health segment was $3,294 in
the fourth quarter, which was flat on a sequential basis despite rate pressures.
Same store agencies decreased $8.0 million and $11.5 million of the decrease
related to agencies closed during the year offset by $8.3 million in revenue
related to start-up and acquisition agencies. The Company announced that it
expects 2011 earnings of $3.00 to $3.30 per share on revenue of $1.60 billion to
$1.65 billion. Analysts on an average were expecting to post earnings of $3.32
per share on revenue of $1.63 billion for the year 2011. Shares of the company
went down by 99 cents or 2.60% and closed at $37.09 after opening at $36.48 and
trading in the range of $37.09-$38.40. Volume of 0.890 million shares has been
traded compared to the daily average of 0.411 million shares. The market
capitalization of the stock stands at $1.08 billion with beta of 0.55 and P/E of
8.20. The 52 week range of the stock is $22.82-$64.28. Amedisys, Inc. (Amedisys)
is a provider of home health services to the chronic, co-morbid, aging American
population. The Company operates in two segments: home health and hospice
segments. Disclaimer: The assembled information distributed by
epicstockpicks.com is for information purposes only, and is neither a
solicitation to buy nor an offer to sell securities. Epicstockpicks.com does
expect that investors will buy and sell securities based on information
assembled and presented herein. EpicStockPicks.com will not be responsible in
any way for or accept any liability for any losses arising from an investor's
reliance on or use of information obtained from our website or emails. PLEASE
always do your own due diligence, and consult your financial advisor.
No comments:
Post a Comment